-transparent.png){kind=logo}
Fourteen insulin-dependent diabetics with symptoms and signs of delayed gastric emptying were treated with a new prokinetic agent, cisapride. In a placebo-controlled cross-over trial no significant differences from placebo was found regarding overall symptomatic effects and effects on gastric emptying of a mixed solid/liquid isotope marked test meal. Solid emptying was most markedly delayed in diabetics compared with healthy controls, but the emptying rate was not correlated to the severity of symptoms as observed for liquid emptying. During active treatment with cisapride the amelioration of symptoms was correlated to increased emptying rates assessed by combined measure of liquid/solid gastric emptying.
T Havelund, and
E Oster-Jørgensen, and
O Eshøj, and
M L Larsen, and
K Lauritsen
April 1982,
Annals of internal medicine,
T Havelund, and
E Oster-Jørgensen, and
O Eshøj, and
M L Larsen, and
K Lauritsen
June 1997,
Alimentary pharmacology & therapeutics,
T Havelund, and
E Oster-Jørgensen, and
O Eshøj, and
M L Larsen, and
K Lauritsen
January 2019,
Journal of diabetes investigation,
T Havelund, and
E Oster-Jørgensen, and
O Eshøj, and
M L Larsen, and
K Lauritsen
August 1999,
Annals of internal medicine,
T Havelund, and
E Oster-Jørgensen, and
O Eshøj, and
M L Larsen, and
K Lauritsen
November 1988,
Clinical pharmacology and therapeutics,
T Havelund, and
E Oster-Jørgensen, and
O Eshøj, and
M L Larsen, and
K Lauritsen
December 1990,
Archives of disease in childhood,
T Havelund, and
E Oster-Jørgensen, and
O Eshøj, and
M L Larsen, and
K Lauritsen
May 1993,
Digestive diseases and sciences,
T Havelund, and
E Oster-Jørgensen, and
O Eshøj, and
M L Larsen, and
K Lauritsen
October 1996,
The Journal of clinical endocrinology and metabolism,
T Havelund, and
E Oster-Jørgensen, and
O Eshøj, and
M L Larsen, and
K Lauritsen
January 1983,
Digestion,
T Havelund, and
E Oster-Jørgensen, and
O Eshøj, and
M L Larsen, and
K Lauritsen
July 1999,
The Journal of clinical endocrinology and metabolism,
